EGFR and head and neck squamous cell carcinoma: On the other hand, deguelin performed well in enhancing the apoptosis inducing activity of EGFR tyrosine kinase inhibitor AG1478 on mutant head and neck squamous cell carcinoma (Baba et al., 2017).